Trial intelligence / Profile preview

Methylphenidate EEG Connectivity in ADHD

NCT02318017Unknown

Sponsor
Sheba Medical Center
Start
Dec 2014
Primary completion
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Methylphenidate Sequence with Placebo Sequence (2 arms). Primary endpoint: Baseline Complex Network connectivity using electrodes signal correlation. Status: unknown.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NCT02318017.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02318017.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call